These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23121557)

  • 21. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.
    Ponath PD; Qin S; Post TW; Wang J; Wu L; Gerard NP; Newman W; Gerard C; Mackay CR
    J Exp Med; 1996 Jun; 183(6):2437-48. PubMed ID: 8676064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.
    Yoshimura T; Oppenheim JJ
    Exp Cell Res; 2011 Mar; 317(5):674-84. PubMed ID: 21056554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.
    Leick M; Catusse J; Follo M; Nibbs RJ; Hartmann TN; Veelken H; Burger M
    Immunology; 2010 Apr; 129(4):536-46. PubMed ID: 20002784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3).
    Caccuri F; Bugatti A; Corbellini S; Roversi S; Zani A; Mazzuca P; Marsico S; Caruso A; Giagulli C
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states.
    Cox MA; Jenh CH; Gonsiorek W; Fine J; Narula SK; Zavodny PJ; Hipkin RW
    Mol Pharmacol; 2001 Apr; 59(4):707-15. PubMed ID: 11259614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of chemokine decoy receptors and their ligands at the porcine maternal-fetal interface.
    Wessels JM; Linton NF; van den Heuvel MJ; Cnossen SA; Edwards AK; Croy BA; Tayade C
    Immunol Cell Biol; 2011 Feb; 89(2):304-13. PubMed ID: 20680026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of the RANTES/MIP-1 alpha receptor (CC CKR-1) stably transfected in HEK 293 cells and the recombinant ligands.
    Proudfoot AE; Power CA; Hoogewerf A; Montjovent MO; Borlat F; Wells TN
    FEBS Lett; 1995 Nov; 376(1-2):19-23. PubMed ID: 8521958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interceptors:--"silent" chemokine receptors].
    Grodecka M; Waśniowska K
    Postepy Hig Med Dosw (Online); 2007; 61():231-9. PubMed ID: 17507871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling.
    Metzemaekers M; Mortier A; Janssens R; Boff D; Vanbrabant L; Lamoen N; Van Damme J; Teixeira MM; De Meester I; Amaral FA; Proost P
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokine sequestration by atypical chemokine receptors.
    Hansell CA; Simpson CV; Nibbs RJ
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1009-13. PubMed ID: 17073739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
    Stanford MM; Issekutz TB
    J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping.
    Ehlert JE; Addison CA; Burdick MD; Kunkel SL; Strieter RM
    J Immunol; 2004 Nov; 173(10):6234-40. PubMed ID: 15528361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
    Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
    Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines.
    Cockwell P; Calderwood JW; Brooks CJ; Chakravorty SJ; Savage CO
    Nephrol Dial Transplant; 2002 May; 17(5):734-44. PubMed ID: 11981057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3.
    Scholten DJ; Canals M; Wijtmans M; de Munnik S; Nguyen P; Verzijl D; de Esch IJ; Vischer HF; Smit MJ; Leurs R
    Br J Pharmacol; 2012 Jun; 166(3):898-911. PubMed ID: 21883151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK.
    Gosling J; Dairaghi DJ; Wang Y; Hanley M; Talbot D; Miao Z; Schall TJ
    J Immunol; 2000 Mar; 164(6):2851-6. PubMed ID: 10706668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis.
    Okamoto Y; Folco EJ; Minami M; Wara AK; Feinberg MW; Sukhova GK; Colvin RA; Kihara S; Funahashi T; Luster AD; Libby P
    Circ Res; 2008 Feb; 102(2):218-25. PubMed ID: 17991878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma.
    Liu YQ; Poon RT; Hughes J; Li QY; Yu WC; Fan ST
    World J Gastroenterol; 2005 Jan; 11(2):164-70. PubMed ID: 15633209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase.
    Smit MJ; Verdijk P; van der Raaij-Helmer EM; Navis M; Hensbergen PJ; Leurs R; Tensen CP
    Blood; 2003 Sep; 102(6):1959-65. PubMed ID: 12750173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.